1,365
Views
13
CrossRef citations to date
0
Altmetric
Perspective

The evidence for multidisciplinary care in Parkinson’s disease

, ORCID Icon &
Pages 539-549 | Received 25 Feb 2020, Accepted 15 May 2020, Published online: 01 Jun 2020

References

  • Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nat Rev Dis Primer. 2017 Mar 23;3:17013.
  • Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007 Jan 30;68:384.
  • Kuhlman GD, Flanigan JL, Sperling SA, et al. Predictors of health-related quality of life in Parkinson’s disease. Parkinsonism Relat Disord. 2019;65:86–90.
  • Santos García D, de Deus Fonticoba T, Suárez Castro E, et al. Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson’s disease patients: results from the COPPADIS Study Cohort. Parkinsonism Relat Disord. 2019;66:151–157.
  • Grimes D, Fitzpatrick M, Gordon J, et al. Canadian guideline for Parkinson disease. CMAJ. 2019 Sept 9;191(36):E989–1004.
  • Gaboury I, Boon H, Verhoef M, et al. Practitioners’ validation of framework of team-oriented practice models in integrative health care: a mixed methods study. BMC Health Serv Res. 2010 Oct 14;10:289.
  • Prizer LP, Browner N. The integrative care of Parkinson’s disease: a systematic review. J Park Dis. 2012;2:79–86.
  • Ouwens M. Integrated care programmes for chronically ill patients: a review of systematic reviews. Int J Qual Health Care. 2005 Apr 1;17:141–146.
  • Armitage GD, Suter E, Oelke ND, et al. Health systems integration: state of the evidence. Int J Integr Care. 2009 June 17;9:e82.
  • World Health Organization. Framework on integrated, people-centred health services. Geneva; 2016. [cited 2020 Jan 9]. Available from: https://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_39-en.pdf?ua=1
  • Goodwin N. Understanding integrated care. Int J Integr Care. 2016;16(4):6.
  • Damery S, Flanagan S, Combes G. Does integrated care reduce hospital activity for patients with chronic diseases? An umbrella review of systematic reviews. BMJ Open. 2016 21;6:e011952.
  • Flanagan S, Damery S, Combes G. The effectiveness of integrated care interventions in improving patient quality of life (QoL) for patients with chronic conditions. An overview of the systematic review evidence. Health Qual Life Outcomes. 2017 Sept 29;15:188.
  • Struckmann V, Leijten FRM, van Ginneken E, et al. Relevant models and elements of integrated care for multi-morbidity: results of a scoping review. Health Policy. 2018 Jan 1;122:23–35.
  • Hébert R, Durand PJ, Dubuc N, et al. PRISMA: a new model of integrated service delivery for the frail older people in Canada. Int J Integr Care. 2003 Mar 18;3:e08.
  • Vlaanderen FP, Rompen L, Munneke M, et al. The voice of the Parkinson customer. J Park Dis. 2019;9:197–201.
  • Reynolds H, Wilson-Barnet J, Richardson G. Evaluation of the role of the Parkinson’s disease nurse specialist. Int J Nurs Stud. 2000 Aug 1;37:337–349.
  • Lennaerts H, Groot M, Rood B, et al. A guideline for Parkinson’s disease nurse specialists, with recommendations for clinical practice. J Park Dis. 2017;7:749–754.
  • Laurant M, van der Biezen M, Wijers N, et al. Nurses as substitutes for doctors in primary care. Cochrane Database Syst Rev. 2018 Jul 16;7(7):CD001271.
  • Jahanshahi M, Brown RG, Whitehouse C, et al. Contact with a nurse practitioner: a short-term evaluation study in Parkinson’s disease and dystonia. Behav Neurol. 1994;7:189–196.
  • Jarman B, Hurwitz B, Cook A, et al. Effects of community based nurses specialising in Parkinson’s disease on health outcome and costs: randomised controlled trial. BMJ. 2002 May 4;324:1072.
  • Radder DLM, Lennaerts HH, Vermeulen H, et al. The cost-effectiveness of specialized nursing interventions for people with Parkinson’s disease: the NICE-PD study protocol for a randomized controlled clinical trial. Trials. 2020 Dec;21;1–11.
  • Connor KI, Cheng EM, Barry F, et al. Randomized trial of care management to improve Parkinson disease care quality. Neurology. 2019 16;92:e1831–42.
  • Bhidayasiri R, Boonpang K, Jitkritsadakul O, et al. Understanding the role of the Parkinson’s disease nurse specialist in the delivery of apomorphine therapy. Parkinsonism Relat Disord. 2016 Dec 1;33:S49–55.
  • Kessler D, Liddy C. Self-management support programs for persons with Parkinson’s disease: an integrative review. Patient Educ Couns. 2017 Oct 1;100:1787–1795.
  • Guo L, Jiang Y, Yatsuya H, et al. Group education with personal rehabilitation for idiopathic Parkinson’s disease. Can J Neurol Sci J Can Sci Neurol. 2009 Jan;36(1):51–59.
  • Lakshminarayana R, Wang D, Burn D, et al. Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson’s disease. npj Parkinson’s Dis. 2017;3:2.
  • Ory MG, Smith ML, Ahn S, et al. National study of chronic disease self-management: age comparison of outcome findings. Health Educ Behav. 2014 Oct 1;41:34S–42S.
  • Shimbo T, Goto M, Morimoto T, et al. Association between patient education and health-related quality of life in patients with Parkinson’s disease. Qual Life Res. 2004 Feb 1;13:81–89.
  • van der Eijk M, Nijhuis FAP, Faber MJ, et al. Moving from physician-centered care towards patient-centered care for Parkinson’s disease patients. Parkinsonism Relat Disord. 2013 Nov 1;19:923–927.
  • Tickle‐Degnen L, Ellis T, Saint‐Hilaire MH, et al. Self-management rehabilitation and health-related quality of life in Parkinson’s disease: a randomized controlled trial. Mov Disord. 2010;25:194–204.
  • A’Campo LEI, Wekking EM, Spliethoff-Kamminga NGA, et al. The benefits of a standardized patient education program for patients with Parkinson’s disease and their caregivers. Parkinsonism Relat Disord. 2010 Feb 1;16:89–95.
  • Gage H, Grainger L, Ting S, et al. Specialist rehabilitation for people with Parkinson’s disease in the community: a randomised controlled trial. Southampton (UK): NIHR Journals Library; 2014. (Health Services and Delivery Research).
  • Qamar MA, Harington G, Trump S, et al. Multidisciplinary care in parkinson’s disease. In: Bhatia KP, Chaudhuri KR, Stamelou M, editors. Chapter 18, International review of neurobiology. Vol. 132; 2017. p. 511–523. Elsevier
  • Bloem BR, de Vries NM, Ebersbach G. Nonpharmacological treatments for patients with Parkinson’s disease. Mov Disord. 2015;30(11):1504–1520.
  • Cohen EV, Hagestuen R, González-Ramos G, et al. Interprofessional education increases knowledge, promotes team building, and changes practice in the care of Parkinson’s disease. Parkinsonism Relat Disord. 2016 Jan 1;22:21–27.
  • Parashos SA. Challenges of multidisciplinary care in Parkinson’s disease. Lancet Neurol. 2013 Oct;12:932–933.
  • Vaughan CP, Prizer LP, Vandenberg AE, et al. A comprehensive approach to care in Parkinson’s disease adds quality to the current gold standard. Mov Disord Clin Pract. 2017 June 15;4:743–749.
  • Miyasaki JM, Kluger B. Palliative care for Parkinson’s disease: has the time come? Curr Neurol Neurosci Rep. 2015 Mar 22;15(5):26.
  • Rochester L, Espay AJ. Multidisciplinary rehabilitation in Parkinson’s disease: a milestone with future challenges. Mov Disord. 2015;30:1011–1013.
  • Eggers C, Dano R, Schill J, et al. Patient-centered integrated healthcare improves quality of life in Parkinson’s disease patients: a randomized controlled trial. J Neurol. 2018 Apr;265:764–773.
  • Fleisher J, Barbosa W, Sweeney MM, et al. Interdisciplinary home visits for individuals with advanced Parkinson’s disease and related disorders. J Am Geriatr Soc. 2018;66:1226–1232.
  • van der Marck MA, Bloem BR, Borm GF, et al. Effectiveness of multidisciplinary care for Parkinson’s disease: a randomized, controlled trial. Mov Disord. 2013;28:605–611.
  • van der Marck MA, Munneke M, Mulleners W, et al. Integrated multidisciplinary care in Parkinson’s disease: a non-randomised, controlled trial (IMPACT). Lancet Neurol. 2013 Oct 1;12:947–956.
  • Ferrazzoli D, Ortelli P, Zivi I, et al. Efficacy of intensive multidisciplinary rehabilitation in Parkinson’s disease: a randomised controlled study. J Neurol Neurosurg Psychiatry. 2018 Aug;89:828–835.
  • Kaseda Y, Ikeda J, Sugihara K, et al. Therapeutic effects of intensive inpatient rehabilitation in advanced Parkinson’s disease. Neurol Clin Neurosci. 2017 Jan;5:18–21.
  • Frazzitta G, Maestri R, Bertotti G, et al. Intensive rehabilitation treatment in early Parkinson’s disease: a randomized pilot study with a 2-year follow-up. Neurorehabil Neural Repair. 2015 Feb;29:123–131.
  • Monticone M, Ambrosini E, Laurini A, et al. In-patient multidisciplinary rehabilitation for Parkinson’s disease: a randomized controlled trial. Mov Disord. 2015;30:1050–1058.
  • Ashburn A, Fazakarley L, Ballinger C, et al. A randomised controlled trial of a home based exercise programme to reduce the risk of falling among people with Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2007 July;78:678–684.
  • Clarke CE, Patel S, Ives N, et al. Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson’s disease: a large pragmatic randomised controlled trial (PD REHAB). Health Technol Assess. 2016 Aug 30;20:1–96.
  • Choudhury TK, Harris C, Crist K, et al. Comparative patient satisfaction and feasibility of a pilot Parkinson’s disease enrichment program. J Geriatr Psychiatry Neurol. 2017 Sept 1;30:253–260.
  • Brittle N, Brown M, Mant J, et al. Short-term effects on mobility, activities of daily living and health-related quality of life of a Conductive Education programme for adults with multiple sclerosis, Parkinson’s disease and stroke. Clin Rehabil. 2008 Apr 1;22:329–337.
  • Lindskov S, Westergren A, Hagell P. A controlled trial of an educational programme for people with Parkinson’s disease. J Clin Nurs. 2007;16:368–376.
  • Sunvisson H, Ekman S-L, Hagberg H, et al. An education programme for individuals with Parkinson’s disease. Scand J Caring Sci. 2001;15:311–317.
  • Montgomery EB, Lieberman A, Singh G, et al. Patient education and health promotion can be effective in Parkinson’s disease: a randomized controlled trial. Am J Med. 1994 Nov 1;97:429–435.
  • Ritter VC, Bonsaksen T. Improvement in quality of life following a multidisciplinary rehabilitation program for patients with Parkinson’s disease. J Multidiscip Healthc. 2019 Mar 20;12:219–227.
  • Marumoto K, Yokoyama K, Inoue T, et al. Inpatient enhanced multidisciplinary care effects on the quality of life for Parkinson disease: a quasi-randomized controlled trial. J Geriatr Psychiatry Neurol. 2019 July;32:186–194.
  • Ellis T, Katz DI, White DK, et al. Effectiveness of an inpatient multidisciplinary rehabilitation program for people with Parkinson disease. Phys Ther. 2008 July 1;88:812–819.
  • Carne W, Cifu D, Marcinko P, et al. Efficacy of a multidisciplinary treatment program on one-year outcomes of individuals with Parkinson’s disease. NeuroRehabilitation. 2005 Sept;20:161–167.
  • Trend P, Kaye J, Gage H, et al. Short-term effectiveness of intensive multidisciplinary rehabilitation for people with Parkinson’s disease and their carers. Clin Rehabil. 2002 Nov 1;16:717–725.
  • Sitzia J, Haddrell V, Rice-Oxley M. Evaluation of a nurse-led multidisciplinary neurological rehabilitation programme using the nottingham health profile. Clin Rehabil. 1998 Oct 1;12:389–394.
  • White DK, Wagenaar RC, Ellis TD, et al. Changes in walking activity and endurance following rehabilitation for people with Parkinson disease. Arch Phys Med Rehabil. 2009 Jan 1;90:43–50.
  • Fründt O, Mainka T, Schönwald B, et al. The Hamburg Parkinson day-clinic: a new treatment concept at the border of in- and outpatient care. J Neural Transm Vienna Austria 1996. 2018;125:1461–1472.
  • Hack N, Akbar U, Monari EH, et al. Person-centered care in the home setting for Parkinson’s disease: operation house call quality of care pilot study. Park Dis. 2015. DOI:10.1155/2015/639494
  • Carne W, Cifu DX, Marcinko P, et al. Efficacy of multidisciplinary treatment program on long-term outcomes of individuals with Parkinsons disease. J Rehabil Res Dev. 2005;42:779.
  • Gage H, Grainger L, Ting S, et al. Specialist rehabilitation for people with Parkinson’s disease in the community: a randomised controlled trial. Health Serv Deliv Res. 2014 Dec;2:1–376.
  • Tan SB, Williams AF, Kelly D. Effectiveness of multidisciplinary interventions to improve the quality of life for people with Parkinson’s disease: a systematic review. Int J Nurs Stud. 2014 Jan;51:166–174.
  • Wade DT, Gage H, Owen C, et al. Multidisciplinary rehabilitation for people with Parkinson’s disease: a randomised controlled study. J Neurol Neurosurg Psychiatry. 2003 Feb 1;74:158–162.
  • Frazzitta G, Bertotti G, Riboldazzi G, et al. Effectiveness of intensive inpatient rehabilitation treatment on disease progression in Parkinsonian patients: a randomized controlled trial with 1-year follow-up. Neurorehabil Neural Repair. 2012 Feb 1;26:144–150.
  • Keus SHJ, Oude Nijhuis LB, Nijkrake MJ, et al. Improving community healthcare for patients with Parkinson’s disease: the dutch model. Park Dis. 2012;2012:543426.
  • Nijkrake MJ, Keus SHJ, Overeem S, et al. The ParkinsonNet concept: development, implementation and initial experience. Mov Disord. 2010;25(7):823–829.
  • Keus S, Munneke M, Graziano M, et al. European physiotherapy guideline for Parkinson’s disease. Mov Disord. 2014;29:191.
  • Kalf J, de Swart B, Bloem BR, et al. Guidelines for speech–language therapy in Parkinson’s disease. Parkinsonism Relat Disord. 2007 Jan;13:S183–4.
  • Sturkenboom I, Thijssen M, Elsacker JG, et al. Guidelines for occupational therapy in parkinson’s disease rehabilitation. 2011, p. 145.
  • Rompen L, de Vries NM, Munneke M, et al. Introduction of Network-Based Healthcare at Kaiser Permanente. J Park Dis. 2020;10:207–212.
  • Giladi N, Manor Y, Hilel A, et al. Interdisciplinary teamwork for the treatment of people with Parkinson’s disease and their families. Curr Neurol Neurosci Rep. 2014 Sept 23;14:493.
  • Campbell M, Fitzpatrick R, Haines A, et al. Framework for design and evaluation of complex interventions to improve health. BMJ. 2000 Sept 16;321:694–696.
  • Fletcher A, Jamal F, Moore G, et al. Realist complex intervention science: applying realist principles across all phases of the Medical Research Council framework for developing and evaluating complex interventions. Evaluation (Lond). 2016 July;22:286–303
  • Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating complex interventions: the new medical research council guidance. BMJ. 2008 Sept 29;337:a1655.
  • Beecher HK. The powerful placebo. J Am Med Assoc. 1955 Dec 24;159:1602–1606.
  • Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41–55.
  • The Gambia Hepatitis Intervention Study. The Gambia Hepatitis Study Group. Cancer Res. 1987 Nov 1;47:5782–5787.
  • Mdege ND, Man M-S, Taylor Nee Brown CA, et al. Systematic review of stepped wedge cluster randomized trials shows that design is particularly used to evaluate interventions during routine implementation. J Clin Epidemiol. 2011 Sept;64:936–948.
  • Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2007 Feb;28:182–191.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.